PMC:7291971 / 244-835 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T8","span":{"begin":29,"end":40},"obj":"NCBITaxon:11118"},{"id":"T9","span":{"begin":41,"end":51},"obj":"SP_7"},{"id":"T10","span":{"begin":126,"end":130},"obj":"UBERON:0001456"},{"id":"T11","span":{"begin":159,"end":166},"obj":"NCBITaxon:10239"},{"id":"T12","span":{"begin":251,"end":261},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T13","span":{"begin":386,"end":393},"obj":"NCBITaxon:10239"},{"id":"T14","span":{"begin":549,"end":559},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T43008","span":{"begin":29,"end":40},"obj":"NCBITaxon:11118"},{"id":"T77356","span":{"begin":41,"end":51},"obj":"SP_7"},{"id":"T38673","span":{"begin":126,"end":130},"obj":"UBERON:0001456"},{"id":"T98319","span":{"begin":159,"end":166},"obj":"NCBITaxon:10239"},{"id":"T93340","span":{"begin":251,"end":261},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T49466","span":{"begin":386,"end":393},"obj":"NCBITaxon:10239"},{"id":"T50627","span":{"begin":549,"end":559},"obj":"CHEBI:35222;CHEBI:35222"}],"text":"used by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition sta"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":126,"end":130},"obj":"Body_part"},{"id":"T5","span":{"begin":416,"end":419},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma24728"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"used by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition sta"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":126,"end":130},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"used by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition sta"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":41,"end":49},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"used by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition sta"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":126,"end":130},"obj":"http://purl.obolibrary.org/obo/UBERON_0001456"},{"id":"T4","span":{"begin":159,"end":166},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T5","span":{"begin":386,"end":393},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"used by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition sta"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":241,"end":250},"obj":"Chemical"},{"id":"T7","span":{"begin":251,"end":261},"obj":"Chemical"},{"id":"T8","span":{"begin":501,"end":510},"obj":"Chemical"},{"id":"T9","span":{"begin":549,"end":559},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"used by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition sta"}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":204,"end":342},"obj":"Sentence"},{"id":"T6","span":{"begin":343,"end":524},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"used by the recently emerged coronavirus SARS-CoV-2 is one significant and unfortunate example of what the world will have to face in the future with emerging viruses in absence of appropriate treatment. The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. We designed bisubstrate inhibitors by mimicking the transition sta"}